rss
J Neurol Neurosurg Psychiatry 1996;60:185-187 doi:10.1136/jnnp.60.2.185
  • Research Article

Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A.

  1. W Mahattanakul,
  2. T O Crawford,
  3. J W Griffin,
  4. J M Goldstein,
  5. D R Cornblath
  1. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

      Abstract

      Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune mediated polyneuropathy for which there are effective therapies. However, not all patients improve with these treatments. Eight patients with CIDP, two with IgG monoclonal gammopathies, were treated with cyclosporin-A (3 to 5 mg/kg/day). In three, this treatment was successful. It was unsuccessful in four patients who were resistant to other treatments and in one who had initially received cyclosporin-A. There were no serious side effects. In selected patients with CIDP, cyclosporin-A is a potentially useful treatment.

      This Article

      1. Abstract
      2. PDF

      Responses

      1. Submit a response
      2. No responses published

      Register for free content

      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

      BMJ Careers - Latest neurology and neurosurgery jobs